Range
2.91 - 3.15
Vol / Avg.
180.7K/2.4M
Div / Yield
-
52 Wk
2.7 - 7.61
Mkt Cap
70.2M
Payout Ratio
-
Open
2.94
P/E
-
EPS
-0.15
Shares
22.3M
Outstanding
22.3M
Total Float
12.3M
Sector: Health Care.Industry: Biotechnology
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV
Q1 2021Est.ActualSurprise
EPS-0.150
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NRBONeuroBo Pharmaceuticals-6.66%70.2M

NeuroBo Pharmaceuticals Frequently Asked Questions

Q

How do I buy NeuroBo Pharmaceuticals (NRBO) stock?

A

You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ: NRBO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroBo Pharmaceuticals's (NRBO) competitors?

Q

What is the target price for NeuroBo Pharmaceuticals (NRBO) stock?

A

The latest price target for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was reported by HC Wainwright & Co. on February 1, 2021. The analyst firm set a price target for 16.00 expecting NRBO to rise to within 12 months (a possible 407.94% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroBo Pharmaceuticals (NRBO)?

A

The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $3.15 last updated Today at 7:45:18 PM.

Q

Does NeuroBo Pharmaceuticals (NRBO) pay a dividend?

A

There are no upcoming dividends for NeuroBo Pharmaceuticals.

Q

When is NeuroBo Pharmaceuticals (NASDAQ:NRBO) reporting earnings?

A
NeuroBo Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is NeuroBo Pharmaceuticals (NRBO) going to split?

A

There is no upcoming split for NeuroBo Pharmaceuticals.

Q

What sector and industry does NeuroBo Pharmaceuticals (NRBO) operate in?

A

NeuroBo Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.